Raia Drogasil (OTCMKTS:RADLY) Stock Falls 6.3% – Should You Sell?

Raia Drogasil S.A. (OTCMKTS:RADLY)’s share price was down 6.3% during trading on Thursday. The company traded as low as $3.44 and last traded at $3.44. Approximately 19,996 shares were traded during trading, a decline of 73% from the average daily volume of 73,955 shares. The stock had previously closed at $3.67.

Raia Drogasil Price Performance

The company’s 50 day simple moving average is $3.69 and its 200-day simple moving average is $3.93. The company has a market capitalization of $4.47 billion and a price-to-earnings ratio of 68.00. The company has a current ratio of 1.41, a quick ratio of 0.58 and a debt-to-equity ratio of 0.99.

Raia Drogasil (OTCMKTS:RADLY) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.05. The firm had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.32 billion. Raia Drogasil had a return on equity of 18.20% and a net margin of 2.97%. On average, equities research analysts predict that Raia Drogasil S.A. will post 0.17 earnings per share for the current fiscal year.

Raia Drogasil Company Profile

Raia Drogasil, now operating under the brand name RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of pharmacies that sells prescription and over-the-counter medicines, personal-care products, cosmetics, health and wellness items, and convenience products.

The company also provides digital shopping and delivery services through its online channels, supporting customers with medication and health-related purchases. Its operations combine physical stores with e-commerce and other healthcare-related services, serving consumers throughout Brazil.

RD Saúde was formed in 2011 through the merger of Drogasil and Droga Raia, two pharmacy chains with roots dating back to the early twentieth century.